DENTSPLY SIRONA Inc

XRAY

Equity

ISIN US24906P1093 / Valor 31773200

NASDAQ (2024-11-21)

USD 18.64+0.65%

DENTSPLY SIRONA Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

DENTSPLY SIRONA Inc is a global leader in the manufacturing of professional dental products and technologies, working in collaboration with partners to develop innovative solutions for dental professionals worldwide. With a mission to transform dentistry and improve oral health on a global scale, the company is dedicated to empowering dental practices, clinics, laboratories, and distributors to deliver top-quality dental care to patients. DENTSPLY SIRONA's research division plays a key role in driving the development of next-generation dental solutions, reflecting the company's commitment to advancing the field of dentistry.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales

DENTSPLY SIRONA Inc. reported net sales of $953 million for the first quarter of 2024, reflecting a decrease of 2.6% compared to the same period in 2023. Organic sales also saw a decline of 1.9% year-over-year.

Net Income

The company achieved a GAAP net income of $18 million, or $0.09 per share, in Q1 2024. This is a significant improvement compared to a net loss of $19 million, or ($0.09) per share, in the first quarter of 2023.

Adjusted Earnings

Adjusted earnings per diluted share for DENTSPLY SIRONA Inc. in Q1 2024 were $0.42, up from $0.39 in the same quarter of the previous year. The adjusted EBITDA margin was 16.8%, slightly higher than the 16.5% reported in Q1 2023.

Cash Flow and Liquidity

Operating cash flow for the first quarter of 2024 was $25 million, a notable improvement from the negative $21 million reported in Q1 2023. The company also paid $29 million in dividends during this period and had $291 million in cash and cash equivalents as of March 31, 2024.

2024 Outlook

DENTSPLY SIRONA Inc. is maintaining its 2024 outlook for organic sales growth in the range of flat to up 1.5%, and adjusted EPS in the range of $2.00 to $2.10. However, the company expects these metrics to trend towards the low end of the provided ranges due to the current macroeconomic environment.

Summarized from source with an LLMView Source

Key figures

-39.9%1Y

-64.6%3Y

-67.4%5Y

Performance

29.3%1Y

31.5%3Y

34.6%5Y

Volatility